Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
There were no other significant differences between the patients with prostate cancer and the healthy controls within the control group.DemographicsPatients (n = 10)Controls (n = 10)Sex (male (%))8 (80%)9 (90%)Age (years)71 (64 to 75)69 (55 to 75)eGFR (mL/min/1.73 m2)NA81 (9)Duration of dialysis (month)32 (19 to 36)NAPrevious fracture6 (60%)2 (20%)Vitamin D therapy (active/native)7 (70%)/3 (30%)0Phosphate binders (calcium/non-calcium containing)5 (50%)/6 (60%)0Calcimimetic therapy3 (30 %)0p-ionized calcium (mmol/L)1.17 (0.08)*1.26 (0.05)p-phosphate (mmol/L)1.73 (0.68)*1.07 (0.21)p-magnesium (mmol/L)0.93 (0.18)0.83 (0.04)p-iPTH (pmol/L)47 (22 to 57)*6 (5 to 8)p-alkaline phosphatase (U/L)114 (62 to 137)75 (60 to 87)Mean (SD) or median (interquartile range) or numbers (percent)* p < 0.05 compared to control group unpaired t-test or Mann Whitney U
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Ten patients on chronic hemodialysis treatment and ten control patients were recruited.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls: a Quantitative [18F]Fluoride PET Study
Study design awaiting verification · Molecular Imaging and Biology · 2023
Original publication title
Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls: a Quantitative [18F]Fluoride PET Study
© The Author(s) 2023
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Chronic kidney disease (CKD) is prevalent in the aging population and increases the risk of fracture 2 to 4 times. We compared optimized quantitative [18F]fluoride PET/CT methods to the reference standard with arterial input function (AIF) to identify a clinically accessible method for evaluation of bone turnover in patients with CKD.
Source: BackgroundAbstract: What methods does the paper describe?
Ten patients on chronic hemodialysis treatment and ten control patients were recruited. A dynamic 60-min [18F]fluoride PET scan was obtained from the 5th lumbar vertebra to the proximal femur simultaneously with arterial blood sampling to achieve an AIF. Individual AIFs were time-shifted to compute a population curve (PDIF). Bone and vascular volumes-of-interest (VOIs) were drawn, and an image-derived-input-function (IDIF) was extracted. PDIF and IDIF were scaled to plasma. Bone turnover (Ki) was calculated with the AIF, PDIF, and IDIF and bone VOIs using a Gjedde-Patlak plot.
Input methods were compared using correlations and precision errors.
Source: MethodsAbstract: Results
The calculated Ki from the five non-invasive methods all correlated to the Ki from the AIF method with the PDIF scaled to a single late plasma sample showing the highest correlations (r > 0.94), and the lowest precision error of 3 to 5%. Furthermore, the femoral bone VOI’s correlated positively to p-PTH and showed significant differences between patients and controls.
Source: ResultsAbstract: Conclusions
Dynamic 30 min [18F]fluoride PET/CT with a population based input curve scaled to a single venous plasma sample is a feasible and precise non-invasive diagnostic method for the assessment of bone turnover in patients with CKD. The method may potentially allow for earlier and more precise diagnosis and may be useful for assessment of treatment effects, which is crucial for development of future treatment strategies.
Source: ConclusionsAuthors’ abstract
Background
Chronic kidney disease (CKD) is prevalent in the aging population and increases the risk of fracture 2 to 4 times. We compared optimized quantitative [18F]fluoride PET/CT methods to the reference standard with arterial input function (AIF) to identify a clinically accessible method for evaluation of bone turnover in patients with CKD.
Methods
Ten patients on chronic hemodialysis treatment and ten control patients were recruited. A dynamic 60-min [18F]fluoride PET scan was obtained from the 5th lumbar vertebra to the proximal femur simultaneously with arterial blood sampling to achieve an AIF. Individual AIFs were time-shifted to compute a population curve (PDIF). Bone and vascular volumes-of-interest (VOIs) were drawn, and an image-derived-input-function (IDIF) was extracted. PDIF and IDIF were scaled to plasma. Bone turnover (Ki) was calculated with the AIF, PDIF, and IDIF and bone VOIs using a Gjedde-Patlak plot.
Input methods were compared using correlations and precision errors.
Results
The calculated Ki from the five non-invasive methods all correlated to the Ki from the AIF method with the PDIF scaled to a single late plasma sample showing the highest correlations (r > 0.94), and the lowest precision error of 3 to 5%. Furthermore, the femoral bone VOI’s correlated positively to p-PTH and showed significant differences between patients and controls.
Conclusions
Dynamic 30 min [18F]fluoride PET/CT with a population based input curve scaled to a single venous plasma sample is a feasible and precise non-invasive diagnostic method for the assessment of bone turnover in patients with CKD. The method may potentially allow for earlier and more precise diagnosis and may be useful for assessment of treatment effects, which is crucial for development of future treatment strategies.
Supplementary Information
The online version contains supplementary material available at 10.1007/s11307-023-01834-5.
Publication and source details
Original title: Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls: a Quantitative [18F]Fluoride PET Study
Dan Fuglø; Anders Løve Paaske Drachmann; Kim Minh Michael Heltø; Lisbeth Marner; Ditte Hansen
Molecular Imaging and Biology · 2023
© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Danish Kidney FoundationRoyal Library, Copenhagen University LibraryOpen access funding provided by Royal Library, Copenhagen University Library
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T17:35:36.188756+00:00
DOI: 10.1007/s11307-023-01834-5 · PMC10598153